不同方案经导管栓塞治疗对肝癌疗效影响的回顾性分析  

Different transcatheter embolization therapy in treatment of 44 patients with hepatocellular carcinoma

作　　者：罗荣光[1] 况圣佳[1] 黄立新[1] 郭贵海[2] 廖述利 舒虹[1] 刘小红[1] 钟嘉玮[2] 

机构地区：[1]南昌大学第一附属医院影像科,南昌330006 [2]南昌大学第一附属医院消化内科,南昌330006

出　　处：《江西医药》2014年第4期283-285,共3页Jiangxi Medical Journal

基　　金：江西省卫生厅科技计划项目(20133036)

摘　　要：目的评价经导管不同方案栓塞治疗对肝癌疗效的影响。方法收集我院2010年收治行经导管栓塞治疗的BCLC分期为A期或B期的肝癌患者44例,根据采用经动脉栓塞(TAE)、经动脉碘油化疗栓塞(TOCE)及联合采用TAE、TOCE及经动脉化疗栓塞(TACE)治疗将其分为TAE组、TOCE组及混合组。结果所有44例患者中入选TAE组21例,入选TOCE组15例,入选混合组8例,3组肝癌患者生存期的差异无统计学意义。结论经导管不同方案栓塞治疗对肝癌患者的生存期无明显影响。Objective To explore the effect of different transcatheter embolization therapy on hepatocellular carcinoma. Methods Forty-four HCC patients with BCLC stage A or stage B were admitted to our hospital and treated by transcatheter embolization therapy in 2010. According to treated by transarterial embolization（TAE）,transarterial oily chemoembolization（TOCE） or combined TAE,TOCE and transcatheter arterial chemoembolization（TACE）,all 44 patients were divided into TAE group,TOCE group and mixed group. Results For all this 44 patients,there were 21 cases in TAE group,15 cases in TOCE group and 8 cases in mixed group,respectively. The survival had no significant difference among these 3 groups. Conclusion The type of transcatheter embolization therapy may be no obvious effect on patients survival.

关 键 词：肝肿瘤 TACE TOCE TAE 介入放射学 

分 类 号：R735.7[医药卫生—肿瘤]